Treatment as Prevention ANRS 12249
South Africa, 2012 - 2016
Get Microdata
Reference ID
ANRS12249TasP
Producer(s)
Dabis, François, Newell, Marie-Louise, Pillay, Deenan
Collections
Metadata
Created on
Jan 30, 2018
Last modified
Jan 30, 2018
Page views
394627
Downloads
4610
- Data files
-
HIV Drug
Treatments - Households
- CHEs
-
Lab Test
Results -
ARTemis Lab
Results -
ARTemis
Patients -
CHE Adverse
Events - SCBs SCCs
-
CHE Action
Plans - Clusters
- Visits
- HHIs
- CFUs
- CFU Pill Tests
- Local Areas
- Census Rounds
- SCIs
-
Individual
Consents -
SAEs Initial
Notifications -
SAEs Initial
Notifications -
Events details -
SAEs Initial
Notifications -
Medications -
SAEs
Complementary
Notifications -
SAEs
Complementary
Notifications -
Medications - CBCs
- Specimens
- IQs
-
Minority
Variants - BMQ Surveys
- NGS Genomics
- Refusals
- NgsAssembQuality
- Sample Genomics
- Locations
- LinkToCareTracker
- Exits
-
ACCDB
Encounters -
ACCDB Encounter
Therapies - Individuals
- Trial Statuses
- DBS results
Reason for stopping (ReasonForStopping)
Data file: HIV Drug Treatments
Overview
Valid:
1046
Invalid:
51191
Type:
Discrete
Decimal:
0
Width:
28
Range:
1 - 16
Format:
Numeric
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| 1 | End of course of treatment | 0 |
0%
|
| 2 | Poor adherence | 14 |
1.3%
|
| 3 | Intolerance - Rash | 2 |
0.2%
|
| 4 | Intolerance - Hepatitis | 8 |
0.8%
|
| 5 | Lactataemia | 16 |
1.5%
|
| 6 | Lactic Acidosis | 32 |
3.1%
|
| 7 | Neuropathy | 44 |
4.2%
|
| 8 | Lipodystrophy | 365 |
34.9%
|
| 9 | Immunological failure | 0 |
0%
|
| 10 | Virological failure | 61 |
5.8%
|
| 11 | Planned interruption | 0 |
0%
|
| 12 | Other | 164 |
15.7%
|
| 13 | Unknown | 6 |
0.6%
|
| 14 | Entry Required | 59 |
5.6%
|
| 15 | Policy change | 229 |
21.9%
|
| 16 | TasP trial switch to Atripla | 34 |
3.3%
|
| 17 | Renal impairment | 12 |
1.1%
|
| Sysmiss | 51191 |
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.
Description
Universe
The patient stopped that regimen.